Urine Monitoring Systems Market Size

Urine Monitoring Systems Market size was valued at USD 5.6 billion in 2024 and is estimated to secure a valuation of USD 13.9 billion by the end of 2037, rising at a CAGR of 7.1% during the forecast period, i.e., 2025-2037. In 2025, the industry size of urine monitoring systems is evaluated at USD 6.0 billion.    

The urine monitoring systems market is expected to witness a rapid surge due to the rising demand for advanced diagnostic tools across healthcare settings. Innovations such as wireless and non-invasive solutions reshape the landscape and make diagnostics accurate and friendly for patients. For example, Bright Uro raised USD 23 million in Series A funding for developing a catheter-free urodynamics system in December 2023, a recent innovation that points to a shift in the direction of improvement not just of patient comfort but of diagnostic accuracy as well. Governments also emphasize the development of diagnostic solutions and encourage grants and policies to look forward to better prospects of using advanced technologies.

The demand for urine monitoring systems is underpinned by ongoing regulatory support and technological advances in widening the scope of critical care and chronic disease management applications. For example, in September 2024, PreAnalytiX GmbH came up with the PAXgene Urine Liquid Biopsy Set to enable the analytically reliable analysis of cfDNA from urine. This launch highlights the focus of companies on precision diagnostics and non-invasive technologies. Furthermore, governments are contributing by investing in healthcare infrastructure, with various grants that are being used to improve the diagnostic capabilities in various regions across the world, hence improving patient outcomes.